<DOC>
	<DOCNO>NCT02537210</DOCNO>
	<brief_summary>The purpose study determine whether aminosalicylic acid ( ASA ) safely withdrawn patient long-standing clinical inactive UC .</brief_summary>
	<brief_title>Aminosalicylic Acid Withdrawal Study Long Standing Inactive Ulcerative Colitis</brief_title>
	<detailed_description>This randomize , double-blind , control trial patient long-standing clinically inactive UC receive ASA maintenance remission randomize either continue 5-ASA receive equivalent placebo 12 month . The primary endpoint clinical relapse 12 month .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Aminosalicylic Acid</mesh_term>
	<mesh_term>Mesalamine</mesh_term>
	<criteria>confirm diagnosis UC accord establish clinical , endoscopic histologic criterion longstanding clinical remission write informed consent allergic mesalazine prior bowel surgery except appendectomy hepatic renal dysfunction malignant disease within 5 year pregnancy breast feed woman childbearing age without regular use contraception antitumor necrosis factor therapy terminal illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>